Edition:
United States

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

44.95USD
2:14pm EST
Change (% chg)

$0.26 (+0.58%)
Prev Close
$44.69
Open
$44.65
Day's High
$45.14
Day's Low
$44.54
Volume
1,759,654
Avg. Vol
2,588,052
52-wk High
$45.58
52-wk Low
$36.76

Select another date:

BRIEF-Abbott Laboratories commences exchange offers, consent solicitations for St. Jude Medical notes

* Abbott laboratories - Abbott commences exchange offers and consent solicitations for St. Jude Medical LLC notes Source text for Eikon: Further company coverage:

BRIEF-Abbott Laboratories says board of directors shall consist of 12 persons from 11

* Abbott Laboratories-on Feb 16, amended by-laws to provide that co's board of directors shall consist of 12 persons, effective as of February 16, 2017

BRIEF-ABBOTT SETS QUARTERLY DIVIDEND OF $0.265 PER SHARE

* SETS QUARTERLY DIVIDEND OF $0.265 PER SHARE Source text for Eikon: Further company coverage:

Abbott Laboratories may see boost from St. Jude's acquisition: Barron's

NEW YORK Abbott Laboratories is likely to see its shares rise again after trading range-bound for nearly a year on the back of its $25 billion acquisition of medical device-maker St. Jude Medical, Barron's said on Sunday.

BRIEF-FDA grants Abbott first commercial authorization for molecular test to detect zika virus using whole blood

* U.S. FDA grants Abbott the first commercial authorization for a molecular test to detect zika virus using whole blood

BRIEF-Abbott announces U.S. approval for its Assurity Mri pacemaker

* Abbott announces U.S. approval for its Assurity Mri pacemaker, the world's smallest, longest-lasting wireless mri-compatible pacemaker Source text for Eikon: Further company coverage:

Abbott pauses on deals, to focus on St. Jude integration

Abbott Laboratories said it planned to focus on slashing its debt and integrating its $25 billion acquisition of St. Jude Medical in 2017, in a break from the hectic pace of dealmaking last year

UPDATE 3-Abbott pauses on deals, to focus on St. Jude integration

* Shares fall as much as 2.6 pct (Adds conference call details, analyst comment; updates shares)

EU mergers and takeovers (Jan 25)

BRUSSELS, Jan 25 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

BRIEF-European Commission clears Abbott acquisition of Alere

* Alere inc - "We remain highly confident that merger will close according to terms of agreement" with Abbott Source text for Eikon: Further company coverage:

Select another date:

More From Around the Web